Discovery of a novel series of CXCR3 antagonists.
暂无分享,去创建一个
Christophe Cleva | André Chollet | Ruggero Dondi | Amanda Proudfoot | Stefano Crosignani | Marc Missotten | Yann Ratinaud | Yves Humbert | Ashis Baran Mandal | Agnès Bombrun | Christine Power
[1] C. Mackay,et al. The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. , 1998, The Journal of clinical investigation.
[2] H. Weiner,et al. CCR5(+) and CXCR3(+) T cells are increased in multiple sclerosis and their ligands MIP-1alpha and IP-10 are expressed in demyelinating brain lesions. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[3] M. Burdick,et al. Role of CXCL9/CXCR3 Chemokine Biology during Pathogenesis of Acute Lung Allograft Rejection 1 , 2003, The Journal of Immunology.
[4] R. Ravid,et al. Multiple sclerosis: a study of CXCL10 and CXCR3 co-localization in the inflamed central nervous system , 2002, Journal of Neuroimmunology.
[5] D. Patel,et al. CXCR3 and CCR5 ligands in rheumatoid arthritis synovium. , 2001, Clinical immunology.
[6] A. Luster,et al. CXCR3 Requires Tyrosine Sulfation for Ligand Binding and a Second Extracellular Loop Arginine Residue for Ligand-Induced Chemotaxis , 2006, Molecular and Cellular Biology.
[7] Jakob S. Jensen,et al. Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients. , 1999, The Journal of clinical investigation.
[8] Rob Leurs,et al. Towards Small‐Molecule CXCR3 Ligands with Clinical Potential , 2008, ChemMedChem.
[9] A. Viola,et al. Chemokines and their receptors: drug targets in immunity and inflammation. , 2008, Annual review of pharmacology and toxicology.
[10] J. Malin,et al. Expression of chemokine receptor CXCR3 on cerebrospinal fluid T-cells is related to active MRI lesion appearance in patients with relapsing–remitting multiple sclerosis , 2002, Journal of Neuroimmunology.